| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT02115282 | Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone… | Anatomic Stage III Breast Cancer AJCC v8 | Active, Not Recruiting |
| Phase 2 | |||
| NCT07330544 | A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant… | Breast Cancer | Recruiting |
| NCT07492394 | Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer | Breast Cancer | Recruiting |
| NCT07441486 | A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and… | Breast Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05053971 | Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and… | Advanced Malignant Solid Neoplasm | Recruiting |
| NCT04708470 | A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including… | Oropharyngeal Cancer | Active, Not Recruiting |
| NCT01038778 | Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney… | Clear Cell Renal Cell Carcinoma | Active, Not Recruiting |
| Phase 1 | |||
| NCT02453620 | Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are… | Anatomic Stage III Breast Cancer AJCC v8 | Active, Not Recruiting |